Applicant, as named in the Orange Book

Acerus

Next listed expiry: Natesto on 17 Mar 2034. 1 products with live protection, 0 without.

Products with listed protection

DrugEarliest generic entry
Natesto
NDA 205488
testosterone
17 Mar 2034
patent, carve-out possible

Recent events

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.